Why Iovance Biotherapeutics Stock Was on Fire Today
An influential investment bank resumed its coverage of the company.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Meta shares soar after launch of Muse AI
Muse is a multitasking AI assistant that is capable of performing tasks on behalf of a user.
5 Energy Stocks Positioned for a Prolonged Iran War
For the first time since the Iran war began, JPMorgan says it no longer has a clear baseline for how the oil market gets out of it.
- Chevron profits surged to $12 billion Q2, with upstream earnings tripling
- Company s Hess acquisition added 900,000 bpd production from Guyana
- Marathon Petroleum benefits from refining margin surge amid Iran conflict
The Rise of the Almost-Premium Credit Card
Higher annual fees on top-tier cards has led to a reshuffling of the market, with cards just below that level targeting the not-quite-rich enough.
StarHub could buy M1 at below Simba’s bid, but funding poses challenge: analysts
StarHub may need to issue new shares or issue shares directly to Keppel as part of the deal, they suggest